OCGN Q2 2023 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$578M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$485,000

Gross Profit

-$14M-2904.9% margin

Operating Income

-$24M-4853.6% margin

Net Income

-$23M-4755.7% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+9.5%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$22M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$89M

Total Liabilities

$19M

Stockholders' Equity

$70M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$485,000	$0	—
Gross Profit	-$14M	$0	—
Operating Income	-$24M	-$20M	-20.3%
Net Income	-$23M	-$19M	-18.5%